Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > NO tech guy HERE
View:
Post by ramrodretired on Mar 15, 2023 5:21pm

NO tech guy HERE

But still hoping to celebrate a new NR with GREEN BEER!
Comment by Oilminerdeluxe on Mar 16, 2023 5:15am
Any chance of an update before the Q4 report? Say what I want to hear, feel free to lie, to please my tired mind. One would think that patience would get easier with the years gone by.
Comment by StevenBirch on Mar 16, 2023 8:08am
Personally I hope they have already applied for BTD therefore I think we are looking for something out of the blue, in between updates. In fact I hope it is a news release saying they have been granted BTD and in it they update the data. A regular update has proven to do nothing to help the stock, I think we all know the data and that it is trending in the right direction. We need an announcement ...more  
Comment by Lesalpes29 on Mar 16, 2023 8:19am
Good post Steven. BTD NR and no more cheap PP please! I hope I don't dream too much! GL
Comment by Oilminerdeluxe on Mar 16, 2023 8:24am
Thanks.
Comment by Rumpl3StiltSkin on Mar 16, 2023 11:14am
Well, I for one am not convinced that BTD will automagically move the stock. I hope I'm wrong but I remember when FT was supposed to move the stock. :-(   AA though, It will be the anouncement that leads to a JV or buyout or other speculations that should move the stock much much higher. And BTD should be the PR that will signal to most, that AA 'could' be soon... :-)
Comment by Yajne on Mar 16, 2023 4:29pm
Steven, if BTD were to come 'out of the blue', then IMO it would be worthy of a trading halt. Lets hope!
Comment by StevenBirch on Mar 16, 2023 4:59pm
I know everyone loves a halt but a pre-open announcement will get the job done just as well. Right now I'll settle for TD to stop knocking it down a couple of cents every day just for the hell of it, on little volume.
Comment by Lesalpes29 on Mar 17, 2023 8:02am
Even if I don't think we will go up heavily when BTD will show up... I don't understand why BTD is not out already. Urgency to give patients an other good alternative seems to be not that urgent! GL
Comment by Rumpl3StiltSkin on Mar 17, 2023 10:08am
I think there is a reasonable chance they have already applied for BTD. FDA has 60 days to respond, I think. So, there must have been some delay, as they originally planned to apply in December.
Comment by ramrodretired on Mar 16, 2023 7:16am
Oh well maybe NEXT THURSDAY!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250